Effect of Gestational Age at Tenofovir-Emtricitabine-Efavirenz Initiation on Adverse Birth Outcomes in Botswana

Among human immunodeficiency virus–positive women in Botswana on the recommended first-line antiretroviral therapy regimen, tenofovir-emtricitabine-efavirenz, initiated within the first or early second trimester, we found no increased risk of stillbirth, neonatal death, preterm/very preterm delivery...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Pediatric Infect Dis Soc
Päätekijät: Zash, Rebecca, Rough, Kathryn, Jacobson, Denise L, Diseko, Modiegi, Mayondi, Gloria, Mmalane, Mompati, Essex, Max, Petlo, Chipo, Lockman, Shahin, Makhema, Joseph, Shapiro, Roger L
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Electronic Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6097579/
https://ncbi.nlm.nih.gov/pubmed/29688554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jpids/piy006
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia